Treatment of type I gastric neuroendocrine tumors with somatostatin analogs

E-ISSN： 1440-1746|25|3|548-554

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.25, Iss.3, 2010-03, pp. : 548-554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 618-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4094-4102

John Wiley & Sons Inc

Access to resources Recommend Favorite

The expanding role of somatostatin analogues in the treatment of neuroendocrine tumours: the CLARINET study

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 6, 2015-12 ,pp. : 759-761

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antitumor Effect of Everolimus in a Patient with Type 3 Gastric Neuroendocrine Tumor

Oncology Research and Treatment, Vol. 36, Iss. 9, 2013-08 ,pp. : 502-504

Karger

Access to resources Recommend Favorite

In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model

MAGNETIC RESONANCE IN MEDICINE, Vol. 74, Iss. 5, 2015-11 ,pp. : 1221-1226

John Wiley & Sons Inc

Access to resources Recommend Favorite